M essenger RNAs, typically found in cells as ribonucleoproteins 1,2 , engage ribosomes, tRNAs and other factors that translate the genetic information transcribed in mRNAs to instruct protein production 3 . Canonical mRNA decay 4 involves deadenylation followed by 3′ -to-5′ exonucleolysis by the exosome 5,6 , and decapping 7,8 followed by 5′ -to-3′ exonucleolysis by XRN1 (ref. 4 ). Numerous trans-acting factors 9,10 and cis RNA elements, including codons 11 , regulate mRNA decay.
Results
Cotranslational 3′-end trimming of capped mRNAs. To investigate human mRNA dynamics in vivo, we initially attempted whole-transcriptome single-molecule real-time (SMRT; PacBio) long-read sequencing of capped RNAs isolated from HeLa cells through a method that we developed called Akron-SMRT (from ακρον, ultimate point, starting or ending; Supplementary Fig. 1a ). In this method, capped RNAs are enriched through digestion with Terminator 5′ phosphate (P)-dependent exonuclease. SMRT did not provide adequate sequencing depth for whole-transcriptome analysis or accurate quantification. Instead, we interrogated randomly selected transcripts and found that they were cotranslationally degraded from the 3′ end while their fragments remained associated with translating ribosomes ( Supplementary Fig. 1b,c) . We verified these findings through high-resolution northern blotting ( Supplementary Fig. 1d -f) and excluded exogenous RNA degradation as the source for fragmentation ( Supplementary Fig. 1g ). through which they are generated. Methods that capture the 5′ ends of polyadenylated mRNAs, such as parallel analysis of RNA ends (PARE)-seq 33, 34 , degradome-seq 35 , genome-wide mapping of uncapped and cleaved transcripts (GMUCT) 36 and 5'-phosphorylated-end sequencing (5Pseq) 13 ; or the 3′ ends of transcripts, such as TAIL-seq 37 , have elucidated fundamental aspects of RNA processing and metabolism. However, existing 5′ -end-sequencing methods do not capture 3′ ends, and TAIL-seq does not discriminate between the 3′ ends of capped and uncapped RNAs. We developed Akron-seq to simultaneously capture and sequence the 3′ ends of capped RNAs (Akron3) and the 5′ ends of polyadenylated RNAs (Akron5) (Fig. 1a ). In both methods, RNA native ends are marked by adapter ligation before fragmentation or cDNA generation and are identified by paired-end sequencing by synthesis ( Fig. 1a ). In Akron3, RNA is digested with Terminator to enrich for capped molecules. Because Terminator does not degrade RNAs bearing 5′ -OH, we also set out to capture such molecules and compare their abundance with that of capped RNAs; however, we found that they were present in negligible amounts ( Supplementary Fig. 2a ). We also attempted to generate Akron3 libraries of 5′ -OH-bearing RNAs but were unable to do so because we did not obtain a specific PCR product ( Supplementary Fig. 2b ). This result was consistent with findings from the Steinmetz laboratory, which has also been unable to generate libraries from RNAs bearing 5′ -OH in Saccharomyces cerevisiae 13 . Thus, Akron3 libraries are overwhelmingly derived from capped RNAs. For Akron5, we isolated polyadenylated RNAs by using oligo(dT) covalently bound to Dynabeads (Fig. 1a ).
By providing reference points for each mRNA end, relative to its beginning (cap) or its end (poly(A)), we were able to interrogate its positional relationships with respect to various mRNA features and processes, including translation, to uncover mechanistic insights into fragment generation. We prepared biological-triplicate (Akron5) and biological-duplicate (Akron3) libraries and found that they were highly reproducible ( Supplementary Fig. 2c,d ). We performed all analyses described below separately for each library and found them to be consistent across all libraries. By measuring the distribution of 3′ ends of capped mRNAs (Akron3) and 5′ ends of polyadenylated mRNAs (Akron5) on meta-mRNA (all mRNAs binned across their length), we found that most ends mapped within the mRNA body ( Fig. 1b,c) . Specifically, we found that ~63.5% of 3′ ends of capped mRNAs mapped within the coding sequence (CDS) of protein-coding genes, and on average only 11% had nontemplated adenines at the 3′ end. The latter mapped primarily at the 3′ ends of genes, as expected ( Fig. 1d,e ). Moreover, by interrogating the 50% most expressed transcripts, as quantified by total-RNAseq, we found that ~63% of those transcripts had Akron3 ends that mapped within the CDS, thus indicating ubiquitous fragmentation.
To examine whether the generation of these native 5′ and 3′ ends was related to translation, we compared Akron-seq with ribosome profiling (ribo-seq) 38 data from HeLa cells 39 . We detected that ribosome-protected fragments (RPFs) mapped overwhelmingly in frame with codons ( Fig. 2a ) and displayed 3-nt periodicity with stop codons (Fig. 2b) , as verified through discrete Fourier transform (DFT) ( Fig. 2c ), which is reflective of the stepwise ribosome movement during translation elongation. Next, we plotted the distribution of Akron5 and Akron3 ends upstream and downstream of RPF 5′ ends ( Fig. 2d,e ), either cumulatively for all transcripts or after dividing them into ten quantiles according to their Akron5 or Akron3 abundance. For controls, we randomized the Akron end positions within the same transcripts, thus maintaining sequence and expression features and eliminating any potential confounding effects from the 3-nt ribosome movement alone. We observed a striking 3-nt periodicity for both ends for all transcripts, in contrast to random controls (Fig. 2f ). PCR with Illumina primers; paired-end sequencing by synthesis This result was verified with DFT ( Fig. 2g ) and indicated cotranslational generation of the 5′ and 3′ ends of mRNA fragments. We found a similar periodicity when we analyzed TAIL-seq data 37 ( Supplementary Fig. 3a ) and when we interrogated long noncoding RNAs loaded with ribosomes ( Supplementary Fig. 3b ), in agreement with recent reports of polysomal association and degradation of long noncoding RNAs 40 . To exclude the possibility that the observed pattern was created by the combined effect of codon-associated nucleotide periodicity and any potential, though unlikely 41 , nucleotide preference by T4 RNA ligase, we downsampled our Akron libraries, constraining the nucleotide content at the Akron ends to 25% for each nucleotide. We found that the plots for the downsampled controls were almost identical to the original libraries, thereby verifying the independence of the observed results from any such bias ( Supplementary Fig. 3c ).
Collectively, our results indicated a universal process of cotranslational RNA degradation that operates on most transcripts that engage with ribosomes. By measuring the positions of Akron5 and Akron3 ends relative to the RPF 5′ ends ( Fig. 2f ), we observed the coincidence of an Akron5 peak and an Akron3 drop around position 0. By experimental design, Akron5 ends corresponded to the 5′ ends of polyadenylated mRNAs, and Akron3 ends corresponded to the 3′ ends of capped RNAs. Therefore, the coincidence of the two signals at position 0 could not have resulted from exonucleolytic trimming initiating from any direction. Along with the 3-nt periodicity and positioning of the Akron5 peak and Akron3 drop relative to the ribosome, these findings indicated that the ends must have been created by an endonucleolytic activity that was associated with the ribosome and that cleaved the translated mRNA as it exited the ribosome channel ( Fig. 2d ; mRNA exit is located between the head and the platform of the 40S subunit).
We hypothesized that the endonucleolytic cut was triggered during translation elongation just upstream of a transiently stalled ribosome (stall marked with a gray box in Fig. 2f , located ~25 nt downstream of RPF 5′ ends) and resulted in the creation of a 5′ and a 3′ mRNA fragment. The 5′ ends of the resulting 3′ fragments coincided with the 5′ ends of RPFs, as evidenced by the increased density at position 0 ( Fig. 2f ). Our hypothesis predicted that the cut around position 0 would result in self-perpetuating mRNA cuts as incoming ribosomes (purple in Fig. 2f ) encountered a hard stall at the cleavage site, thus triggering upstream cuts on the 5′ fragment. The fragments generated by this iterative endonucleolysis were expected not to contain a cap and therefore not to be captured by Akron3. This hypothesis was verified by the characteristic depletion of Akron3 ends around position 0 ( Fig. 2f ). According to our model, the incoming stalled ribosomes on the 5′ fragment were expected to result in accumulation of RPFs upstream of the initial cut sites captured by Akron5. This scenario was reflected in our analysis as increased density in the area immediately to the right of position 0. This result occurred because RPFs were used as reference points, and their 5′ ends were positioned at 0 on the x axis (positive positions on the x axis indicate Akron5 ends located downstream of RPFs). Interestingly, we observed that the highest density in this region was at position + 15, corresponding to the distance of the 5′ end of an incoming ribosome that is stalled at the initial cut site and the cut site itself, which is now located at the peptidyl (P) site, as previously described 42 . Finally, we hypothesized that the depletion of Akron5 and Akron3 ends at the stall site resulted from protection of that region, which was likely to be attributable to the nature of the stall mechanism itself. We simulated core aspects of this model, such as the transient ribosome stall, the resulting upstream endonucleolytic cut and propagating cuts by an incoming ribosome, as well as the putative protection at the stall site. The simulation recreates all characteristics of the experimentally derived Akron5 plot, thus supporting the theoretical foundation of our interpretation ( Supplementary Fig. 3d ).
The process that we describe is conceptually similar to NGD; however, it is not a surveillance pathway of aberrant mRNAs but instead is a widespread and ubiquitous mechanism that degrades canonical mRNAs. We have termed this process 'ribothrypsis' (from θρύπτω, to fragment). Our model predicts that the ribothrypsis nuclease, which we refer to as ribothrypsin, should act endonucleolytically; hence, ribothrypsin cannot be XRN1, the exosome or the SMG6 endonuclease, which can mediate NMD. Additionally, we predict that if the process is ubiquitous, then ribothrypsis products with 5′ and 3′ ends defined by this process should be observable in RNA-seq when no RNA fragmentation is performed, such as in small RNA (sRNA)-seq. Furthermore, our model implies the generation of final ribothrypsis products (FRTPs) ~16 nt in length, corresponding to the distance from the first cut, which now resides at the P site of the incoming ribosome and stalls the ribosome (purple in Fig. 2f ), and the subsequent cut upstream of the stalled incoming ribosome.
Ribothrypsis is not mediated by XRN1. Xrn1 has been shown to closely follow the last translating ribosome and to define the 5′ ends of mRNAs, captured by 5Pseq, during 5′ -to-3′ cotranslational degradation in yeast 13 . However, according to our model, XRN1 cannot be ribothrypsin, although it could still polish the 5′ ends of RNAs after ribothrypsis cuts. To examine the role of XRN1, we analyzed data from Akron5 as well as PARE-seq (which is similar to Akron5), which were obtained from HeLa cells after XRN1 knockdown (KD) 34 . If XRN1 mediates the process, we would expect abrogation of the 3-nt periodicity and of the signal around the RPF 5′ end in XRN1-KD. We calculated the distribution of Akron5 and PARE-seq 5′ ends around the stop codon and around the 5′ ends of RPFs. We detected 3-nt periodicity, as confirmed by DFT, upstream but not downstream of the 5′ end of the terminating ribosome in Akron5 and PARE XRN1-KD ( Fig. 3a,b ), thus verifying that cotranslational ribothrypsis cuts are not mediated by XRN1. In a plot of the distribution of 5′ ends around RPFs, the peak in PARE XRN1-KD was displaced ~2 nt upstream of position 0 ( Fig. 3c ) relative to Akron5 data ( Fig. 2f ), thus supporting a role of XRN1 in polishing the 5′ ends after ribothrypsis. We wondered whether ribothrypsis might also operate in S. cerevisiae and consequently reanalyzed 5Pseq data from wild-type yeast (grown in complete medium (YPD)) and from an Xrn1-deletion (Xrn1∆) strain 13 . We calculated the distribution of 5Pseq 5′ ends around the stop codon and around the RPF 5′ ends, which we obtained from wild-type yeast grown in YPD 42 ( Supplementary Fig. 4a ). As previously reported 13 , we found 3-nt periodicity upstream of the 5′ end of the terminating ribosome in wild-type yeast, as confirmed by DFT, and a peak at position -18 (as measured from the last nucleotide of the stop codon, which was set at 0), a result indicative of cotranslational degradation by Xrn1 that stopped at the terminating ribosome ( Supplementary Fig. 4b ). As previously reported 13 , the -18 peak disappeared in Xrn1∆, but we found, and verified by DFT, that the 3-nt periodicity upstream of the terminating ribosome persisted, arguably at a lower level ( Supplementary Fig. 4c ). We also observed marked 3-nt periodicity between RPFs and the 5′ ends of mRNAs of wild-type ( Supplementary Fig. 4d ) and Xrn1∆ yeast ( Supplementary Fig. 4e ). These findings indicated that ribothrypsis probably operates in S. cerevisiae, and Xrn1 polishes the 5′ ends of transcripts after ribothrypsis cuts. Unlike 5Pseq in yeast, Akron5 did not show enrichment at position -17 from the stop codon ( Fig. 3a) , thus suggesting that Xrn1 may play a larger role in RNA decay in yeast than in humans.
Ribothrypsis footprints in sRNA-seq libraries.
As hypothesized on the basis of our model, if ribothrypsis is prevalent, then its footprints should be observable in sRNA-seq libraries, which capture endogenous 5′ and 3′ ends through adapter ligation and, unlike classic RNA-seq libraries, are not subjected to fragmentation, thus preserving the endogenously produced mRNA ends. We mined deeply sequenced HeLa sRNA libraries (average read length of ~60 nt) 43 and examined the distributions of 5′ and 3′ ends of sRNAs mapping to mRNAs, relative to 5′ ends of RPFs. We found a striking 3-nt periodicity indicative of cotranslational generation of these ends, as well as similar density plots to those of Akron5 and Akron3 (Fig. 3d,e ). As revealed by Akron5, polyadenylated RNAs are subject to ribothrypsis ( Fig. 2f,g) , thus eliminating the exosome as a candidate for ribothrypsin, because the exosome attacks mRNAs after deadenylation. The 3-nt periodicity and density plots were identical between sRNA libraries from wild-type HeLa cells and sRNA-seq libraries after KD of RRP40, a core exosome component, or after triple KD of all exosome nucleases (DIS3, DIS3L and RRP6) 43 (Fig. 3f,g and Supplementary Fig. 5a,b ). These findings indicated that sRNAs may be used as proxies to investigate cotranslational mRNA decay and supported our model's prediction that the exosome is not ribothrypsin. However, they do not preclude functions of the exosome and the Ski complex in clearing ribothrypsis products, even those bound to ribosomes 44 ; or in initiating ribothrypsis during 3′ -to-5′ exonucleolysis, as the exosome starts degrading CDS. In principle, exosome-mediated trimming 42 or cleavage by other RNases (such as Ago proteins programmed with microRNAs or small interfering RNAs 45, 46 ) may be an important trigger for ribothrypsis.
Because our protocols probe canonical mRNAs, we reasoned that SMG6, an endonuclease that can initiate degradation of aberrant mRNAs subjected to NMD, is unlikely to be ribothrypsin. Indeed, when we analyzed the distribution of RPF 5′ ends compared with the 5′ ends of PARE-seq reads from HeLa cells after double KD of SMG6 and XRN1, we found that the 3-nt periodicity and density plot profiles were retained (Fig. 3h ), thus ruling out SMG6 as ribothrypsin.
To investigate whether we could detect final ribothrypsis products (FRTPs; Fig. 2f ) in sRNA libraries, we interrogated RNAs smaller than 17 nt (ref. 43 ) and examined the distributions of their 5′ and 3′ ends relative to the 5′ ends of Akron5 reads. We found that the 5′ ends of sRNAs peaked ~16 nt upstream of Akron5 ends, whereas the 3′ ends of sRNAs peaked immediately upstream of Akron5 ends, in agreement with the designation of these ~16-nt sRNAs as FRTPs ( Supplementary Fig. 5c ). Collectively, all findings presented above supported the ribothrypsis model.
Features of ribothrypsis.
We initially asked whether ribothrypsis might be related to the transcript abundance (calculated from RNAseq from rRNA-depleted total RNA); lengths of CDS and untranslated regions (UTRs); average density of ribosomes per transcript (calculated from ribo-seq and RNA-seq); or RNA stability (calculated from 5′ -bromouridine immunoprecipitation chase (BRIC)-seq 47 ), but we did not identify any correlations between Akron ends and these features (data not shown). Next, we examined the distribution of codons around Akron5 and Akron3 ends. For controls, we randomized end positions within the same transcripts, maintaining the expression levels, nucleotide content and open reading frame (ORF) at the cut site. We observed an enrichment in the lysine K(AAG) codon downstream of Akron5 ends ( Supplementary Fig. 6 ) and an enrichment in K(AAG; AAA) at Akron3 ends ( Supplementary Fig. 7) , as compared with controls, thus suggesting potential ribosome stalling at these codons. Prior reports have documented stalling in lysine codons or during translation of poly(A) tails that drive mRNA cleavage 24 . We note, however, that the ribothrypsis ends mapped by Akron5 and Akron3 were within the CDS of canonical mRNAs, not in poly(A) sequences (generated from normal or premature polyadenylation) or in consecutive stretches of lysines (data not shown), thus suggesting a role for the codons themselves in ribothrypsis. Furthermore, we found enrichment in aspartate D(GAC) and glutamate E(GAA) codons upstream of Akron3 ends ( Supplementary  Fig. 7) . Remarkably, aspartate and glutamate codons, particularly the same E(GAA) codon that we found to associate with Akron3 ends, have been reported to associate with ribosome pausing in mouse embryonic stem cells 48 , probably because of a more open RNA structure at these codons 49 . Our findings support the roles of specific codons in ribothrypsis, although mechanisms are lacking and will be an important pursuit for future studies. More generally, the relationships among ribothrypsis, codons and translation will need to be addressed as understanding improves regarding codons' effects on mRNA structure, codon optimality, codon usage and translation efficiency in humans.
We then reasoned that mRNA structure might trigger or associate with ribothrypsis. We first used RNAfold to predict secondarystructure potential around Akron5 ends that mapped in CDS and found a marked decrease in secondary structure around ribothrypsis cuts and an increase immediately downstream (Fig. 4a ). Modification of RNA bases by chemicals, such as dimethyl sulfate (DMS) is widely used to probe RNA structure or protein footprints on RNA, as identified by next-generation sequencing 50 that captures the stalling of commonly used viral-derived reverse transcriptases (RT-stop) as they encounter modified bases 51 . We compared Akron5 data against in vivo DMS-seq data from HeLa cells 51 and found a sharp increase in DMS values around position 0, a result indicative of high DMS reactivity and consistent with high RNA accessibility around ribothrypsis cuts (Fig. 4b) . Although some of the DMS value may have been due to RT-fall at ribothrypsis cuts, rather than to RT-stop at DMS-modified bases, these results, when combined with structure prediction, indicated RNA accessibility to the ribothrypsis endonuclease at these sites and increased structure immediately downstream of the cuts.
RNA G quadruplexes as potential ribothrypsis triggers. RNA G quadruplexes (rG4) are secondary structures formed by self-association of guanine tetrads into square planar arrangements that stack on top of each other and are stabilized by potassium or other cations 52 . rG4s are very stable in vitro 52, 53 , although they are largely unfolded by proteins and other factors in vivo 54 . We used an algorithm that we had previously used and validated for rG4 detection in Piwi-interacting-RNA precursors 55 , to predict genome-wide rG4 locations and compare them to ribothrypsis cut sites. We identified a striking rG4 enrichment downstream of Akron5 ends (green line in Fig. 5a ), which corresponded closely to the predicted ribosome stall site in our model (Fig. 2f ). Within CDS, rG4s are known to repress protein output by impeding ribosome progression and to exhibit the largest suppression when located at position + 2 relative to the ORF (ORF2) 56 . Remarkably, our data also showed that rG4s in ORF2 corresponded to the highest enrichment downstream of Akron5 ends ( Fig. 5a ; blue line). Overall, we found that ~43% of Akron5 ends had rG4s within a 100-nt region downstream. We found similar rG4 enrichment immediately downstream of PAREseq ends after KD of XRN1 or both XRN1 and SMG6 (Fig. 5b,c) . We did not observe any rG4 enrichment in random controls (Fig. 5a-c) , which we generated by randomizing Akron end positions within the same transcripts (maintaining sequence and expression features). To verify that the signal was specific to rG4s and was not due to increased G content, we shuffled the sequences around Akron5 ends, maintaining expression and nucleotide and codon composition, and found that there was no rG4 enrichment in these shuffled controls (Fig. 5a-c) . Next, we examined the distribution of experimentally detected rG4s (after rG4-seq in HeLa cells 53, 54 ) and also detected enrichment immediately downstream of Akron5 ends (Fig. 5d,e ). Moreover, we identified that the areas around ribothrypsis cuts, particularly regions with an rG4 downstream, were preferentially conserved in vertebrates (Fig. 5f ). rG4 enrichment downstream of putative ribothrypsis cleavages was also conserved in yeast, in both wild-type and Xrn1Δ strains ( Supplementary Fig. 8 ). Together our findings support a role of conserved mRNA areas and increased rG4s, which probably cause transient ribosome stalling, among ribothrypsis triggers.
Discussion
The prevailing view of canonical mRNA decay is that it is an exonucleolytic process mediated by XRN1 and by the exosome and Ski complex. Our findings uncovered a previously undescribed pathway of canonical mRNA decay, which we term ribothrypsis ( Fig. 6 ) and revealed its important features: first, that the decay of canonical mRNAs is also endonucleolytic; second, that this decay is mediated by translating ribosomes; third, that mRNA-decay fragments persist in cells; and fourth, that, like any process that affects all mRNAs (such as mRNA splicing or mRNA translation), ribothrypsis is almost certainly regulated. Why do cells use ribothrypsis for mRNA decay? We hypothesize that the ribosome and its associated ribothrypsin can integrate numerous inputs in real time on each mRNA molecule. This intimate connection between mRNA translation and mRNA decay, orchestrated by the ribosome, allows for exquisite integration and compartmentalization of post-transcriptional gene expression regulation on each transcript.
Recently, two papers have described the contribution and features of NGD in the decay of Ire-1-cleaved mRNAs during activation of the unfolded-protein response in fission yeast 57 and the role of ribosome collision as a critical trigger of NGD in budding yeast 58 . In these cases, the endonuclease 'NGDase' associates with the ribosome and cleaves the mRNA as it exits the ribosome 57, 58 .
Our results are consistent with the findings from these reports and suggest that a ribosome-mediated mechanism of mRNA decay may be a unifying feature that underlies all mRNA decay and is not limited to mRNA surveillance and clearance of aberrant or select mRNAs. Even though the identity of the nuclease remains unknown, molecular mechanisms that mediate mRNA cleavage in ribothrypsis and NGD are likely to be connected. However, we expect that there will also be differences in how the two processes are triggered and regulated. For example, mRNA truncation or base damage by oxidation 59 elicits NGD on defective mRNAs. However, we expect that numerous factors will trigger ribothrypsis on canonical nondamaged mRNAs, for physiological regulation and not for quality control. We identified rG4s as likely triggers of ribothrypsis, but we believe that this finding may represent the tip of the iceberg, in that many other factors, transcript specific or global, are likely to activate and regulate ribothrypsis.
Characterization of the chemical groups that mark the ends of the cleaved products may provide clues to assist in the identification of ribothrypsin. From our findings and those from the Steinmetz laboratory 13 , 5′ -P-bearing mRNA fragments are abundant in HeLa cells and budding yeast, thus suggesting that ribothrypsin generates 3′ fragments bearing 5′ -P. In this case, ribothrypsis products are immediately accessible to XRN1, which degrades RNAs bearing 5′ -P, and ribothrypsin is likely to be a protein whose cleaved products bear 5′ -P (3′ fragment) and 3′ -OH (5′ fragment). However, we note that the Hesselberth laboratory has been able to selectively capture and sequence the small amounts of RNAs bearing 5′ -OH termini from budding yeast, by using RtcB RNA ligase, and has found that such fragments originate from CDS regions of numerous mRNAs 60 . Intriguingly, 5′ -OH fragments appear to accumulate upstream of codons for acidic and basic amino acids 60 . These 5′ -OH termini might be products of ribothrypsis (although further work is required to test this possibility); in that case, ribothrypsin would probably generate 3′ fragments bearing 5′ -OH and 5′ fragments bearing 2′ ,3′ -cyclic phosphate. Ribozymes, in addition to proteins, generate such ends when cleaving RNA, and given that rRNA is essential for the peptidyltransferase activity of the ribosome, rRNA may conceivably also play a key role in ribothrypsis. If ribothrypsin generates 5′ -OH, a kinase would need to phosphorylate the 5′ -OH-bearing fragments to make them substrates for XRN1. We expect that identification of ribothrypsin should provide critical biological insights into mRNA translation and decay. Furthermore, we believe that our work may set the stage for many future investigations, including identification of factors and pathways that trigger or regulate ribothrypsis in normal cellular functions and in disease; and mechanistic investigation of the intersection of ribothrypsis with mRNA translation and turnover. The new methods for capturing RNA ends and the computational approaches, scripts and analyses described here may also be useful for analyzing and simulating RNA processes in general. Finally, our findings have implications for studies investigating gene expression through RNA-seq, microarrays, RT-PCR and related approaches, which are among the most commonly used methods of profiling gene expression. An implicit, almost axiomatic, assumption made by users of these methods is that mRNAs exist largely as full-length molecules in vivo. On the basis of this assumption, fragmentation of the isolated RNA is used to prepare libraries suitable for sequencing by synthesis. The sequencing reads from each mRNA are then used for downstream analyses, such as ranking them to calculate expression levels; deciphering expression signatures used to identify cell types; or performing other analyses limited only by researchers' imagination. Similarly, microarrays use probes that hybridize to only a few areas on each transcript, but then the signals are extrapolated to full-length molecules. RT-PCR amplifies a small amplicon from each mRNA, yet the small amplified fragment is assumed to derive from a larger full-length molecule. Polysome profiling to assess ribosome loading and translation of mRNAs also assumes that mRNAs undergoing translation are largely full length. Our finding that mRNA fragments are generated cotranslationally and are naturally abundant in living cells needs to be considered and opens new possibilities for the interpretation of RNA-seq and other experiments used to interrogate gene expression.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0042-8.
Cell culture. HeLa cells obtained from ATCC (ATCC0 CCL-2.1) were maintained in DMEM (Gibco) supplemented with 10% FBS (Sigma), at 37 °C in 5% CO 2 . Cells were harvested at ~80% confluence. The cells were free of mycoplasma.
Polysome analysis. Cells were pretreated with 100 µ g/ml cycloheximide (CHX, Sigma) at 37 °C for 10 min, washed twice with cold 1× PBS plus 100 µ g/ml CHX, and collected in lysis buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl and 2.5 mM MgCl 2 ) supplemented with 100 µ g/ml CHX, complete EDTA-free protease inhibitor (Roche) and 500 U/ml RNasin RNase inhibitor (RNasin, Promega). Cells were passed through a 25-G syringe, incubated on ice for 10 min and centrifuged to clear nuclei. Cytoplasmic extracts were layered on top of a 10-50% sucrose gradient and were ultracentrifuged at 38,000 r.p.m. for 2 h (Beckman SW41-Ti rotor) at 4 °C. Polysome profiles were recorded via absorbance at 254 nm (ISCO). Fourteen fractions of equal volume were collected and digested with 400 µ g/ml proteinase K (Roche) and 1% SDS at 37 °C for 30 min; total RNA was then extracted with TRIzol (Ambion).
Northern blotting. Total RNA was extracted from polysome fractions with TRIzol. RNA was pooled from fractions corresponding to light (6) (7) (8) (9) or heavy (10) (11) (12) (13) (14) polysomes or from all polysome fractions (6) (7) (8) (9) (10) (11) (12) (13) (14) . Total RNA or RNA from input and sucrose-gradient fractions were treated with Terminator exonuclease (Epicentre) to remove noncapped, 5′ -phosphate (P)-bearing RNAs by incubation at 30 °C for 1 h according to the manufacturer's instructions. RNA was ethanol precipitated and resolved on 6% denaturing PAGE and was transferred to a Hybond N + nylon membrane (GE Healthcare) in 0.5× TBE in a semidry transfer system (Amersham Biosciences). RNA was UV-cross-linked (Stratagene) to the membrane and prehybridized in ULTRHyb-oligo buffer (Ambion). The probe was internally labeled with [α -32 P]UTP with a T7 MEGAshortscript kit (Ambion) and purified with Sephadex G-50 columns (GE Healthcare). Hybridization was carried out in ULTRHyb-oligo buffer. Membranes were washed twice with 2× SSC buffer plus 1% SDS, and twice with 0.5× SSC buffer plus 0.1% SDS, and signals were detected through storage-phosphor autoradiography (Amersham). For quantification, the entire region covering the full length and smear was selected in a rectangular box in ImageJ (v 1.46r), and the signal from the entire region was considered to be 100%. A rectangular box with the same width but covering only the area corresponding to the full-length signal was then selected. To obtain an estimate of the full-length percentage, the signal of the full length was divided by the total signal. Ribosome immunoprecipitation from polysome fractions and western blotting. Polysome fractions (6) (7) (8) (9) (10) (11) (12) (13) (14) were pooled from two sucrose gradients and were diluted in IP binding buffer (20 mM HEPES, pH 7.0, 150 mM NaCl, 5 mM MgCl 2 and 0.05% Triton X-100) supplemented with 500 U/ml RNasin, 40 µ g/ml digitonin and complete EDTA-free protease inhibitor. Samples were incubated with prewashed protein A Dynabeads (Invitrogen) that were conjugated to an antibody against RPL7A (A300-749A, Bethyl Laboratories) or to nonimmune serum as a negative control. Samples were nutated at 4 °C for 4 h, then centrifuged at 3,000 r.p.m. for 10 min to collect beads. Beads were washed five times with IP binding buffer. An aliquot was used for western blotting (WB), and the rest was incubated with IP elution buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 10 mM EDTA and 1% SDS) at 95 °C for 3 min. RNA was recovered through TRIzol extraction and processed for northern blotting. For WB, beads were heated at 95 °C for 10 min; proteins were resolved on 4-12% NuPAGE gels (Invitrogen), transferred to nitrocellulose membranes and probed with anti-RPL7A at 1:5,000 as described previously 61 .
Preparation of Akron-SMRT sequencing libraries.
Total RNA from HeLa cells and polysome fractions (light, 6-9; heavy, 10-14) was extracted with TRIzol. RNA was treated with Terminator to remove noncapped, 5′ -P-bearing RNAs. RNA was precipitated with one volume of 5 M lithium chloride and further treated with calf intestinal phosphatase (CIP, NEB) at 37 °C for 30 min. RNA was recovered with AMPure-XP beads (Beckman) according to the manufacturer's protocol.
For library construction, RNA was ligated to a 3′ -biotinylated RNA adapter (REL3) with T4 RNA ligase (Fermentas) plus 500 U/ml RNasin and incubated at 16 °C for 16 h. Ligated RNA was treated with Terminator to remove excess adapter. RNA was recovered with AMPure-XP beads and was captured with M-280 streptavidin Dynabeads (Invitrogen). Beads were washed twice with 2× bind/wash (BW) buffer (10 mM Tris, pH 7.5, 1 mM EDTA and 2 M NaCl) and twice with 1× BW buffer (5 mM Tris, pH 7.5, 0.5 mM EDTA and 1 M NaCl), then resuspended in RNase-free water. cDNA was generated under conditions favoring full-length amplification. RNA was reverse transcribed with Superscript III (Invitrogen) primed with RT primer (REL3-RT; complementary to the 3′ adapter) plus saturated trehalose (at 50 °C for 45 min, 55 °C for 15 min and heat inactivation at 70 °C for 10 min). RNA was hydrolyzed in 0.11 N NaOH at 98 °C for 20 min. cDNA was ethanol precipitated and PCR amplified with KAPA HiFiHotStartReadyMix (KAPA Biosystems) and 10 µ M primers that contained SMRT barcodes and corresponded to the 5′ UTR (forward, CDK4 F0 or TUBB F0; reverse, REL3-RT). Reactions were run at 98 °C for 2 min; 20 cycles of 98 °C for 30 s, 57 °C for 30 s and 72 °C for 2 min; and 72 °C for 5 min. Re-PCR was set up with 10 µ M primers that corresponded to the start codon (forward, CDK4 F1 or TUBB F1; reverse, REL3-1 or REL3-2) and was run at 98 °C for 2 min; six cycles of 98 °C for 30 s, 57 °C for 30 s and 72 °C for 2 min; and 72 °C for 5 min. PCR products were resolved on 2% MetaPhor gel (Lonza), and fragments (350-850 bp and 900-4,000 bp) were excised for each gene and purified with a GeneJet kit (Thermo Scientific). SMRTbell sequencing libraries were prepared by Pacific Biosciences through a P6-C4chemistry and sequencing protocol. Each size-selected library was sequenced on two SMRT cells. For all analyses, only circular consensus (CCS) reads were used.
As an internal control, a polysome pool was spiked in with Renilla luciferase mRNA before total RNA extraction and Terminator digestion. Luciferase mRNA was generated in vitro with a T7 MegaScriptTranscription kit (Ambion) in the presence of a synthetic RNA-cap analog (NEB) and [α -32 P]UTP. RNA was resolved on 6% denaturing PAGE and visualized by autoradiography (GE Healthcare).
Preparation of Akron sequencing libraries. DNA-free total RNA (~250 µ g) was used as an input to generate both Akron3 and Akron5 libraries. The integrity of mRNA was assessed before library preparation with an RNA Bioanalyzer or agarose gel. After the initial treatment, all protocols converged into the same RNAligation and downstream library-preparation steps with minor modifications.
Preparation of Akron3 libraries. Initially, we used rRNA depletion before proceeding to Akron3 library preparation, but we noticed that our sequences contained substantial amounts of capped noncoding sRNAs, including uridinerich, small nuclear RNAs (U snRNAs). To remove these abundant capped RNAs, sRNAs < 200 bp were first removed from total RNA with SPRIselect beads (Beckman) according to the manufacturer's protocol and then used as input for both Akron3 and Akron5.
To capture 3′ ends of capped (non-and poly(A) RNAs), snRNAs and rRNAs were depleted. We used our own sequencing data to design oligonucleotides (oligos) against abundant snRNAs and published oligos to remove rRNAs 62 . A cocktail of the sn/rRNA oligos containing biotinylated 3′ ends was prepared on the basis of the abundance of each targeted sn/rRNA (that we calculated according to our initial sequencing runs). Total RNA (~5-6 µ g per reaction) was incubated with the cocktail mix in 1× SSC buffer in a thermal cycler (at 75 °C for 5 min, 0.1 °C/s to 37 °C and 37 °C for 45 min). Samples were incubated with MyOne streptavidin C1 Dynabeads (Invitrogen) that were resuspended in 2× BW buffer through mixing at 1,000 r.p.m. for 15 min at 37 °C. Depleted total RNA was precipitated with 100% ethanol, 3 M NaOAc, pH 5.5, and 2 µ g glycogen (Ambion). To remove noncapped, 5′ -P-bearing RNAs, samples were Terminator digested, as described for Akron-SMRT. T4 PolyNucleotide Kinase (PNK, NEB) treatment is optional before Terminator digestion to remove residual 5′ -OH RNAs.
For library construction, depleted and Terminator-digested RNA (~5 µ g) was ligated to a 5′ -P and 3′ -biotinylated RNA adapter (A3-RL3) with T4 RNA ligase in a mixture containing 5% polyethylene glycol (PEG, NEB) and 500 U/ml RNasin at 16 °C for 16 h. Ligated RNAs were fragmented in 1× RNA fragmentation buffer (Ambion) at 70 °C for 7 min. The fragmented RNA was ethanol precipitated and resolved on 6% denaturing PAGE. Fragments > 400 bp were excised, and RNA was eluted from gel pieces by crushing and shaking at room temperature in elution buffer (300 mM NaCl, 10 mM Tris-HCl, pH 7.5, and 1 mM EDTA) plus 500 U/ml RNasin. RNA was ethanol precipitated and incubated with M280 streptavidin Dynabeads. RNA 5′ ends were phosphorylated on beads through T4 PNK treatment at 37 °C for 1 h, and beads were washed with 1× BW buffer.
RNA was then ligated to a 5′ RNA adapter (A3-RL5) with T4 RNA ligase plus 15% PEG and 500 U/ml RNasin at 16 °C for 16 h. After beads were washed, RNA was reverse transcribed with Superscript III primed with 2.5 µ M DP3-RT primer (at 50 °C for 45 min, 55 °C for 15 min and heat inactivation at 90 °C for 3 min). Samples were amplified through PCR with AccuPrimePfxSuperMix (Invitrogen) and 10 µ M primers (DP3 and DP5), run at 94 °C for 2 min; 16 cycles of 94 °C for 20 s, 58 °C for 30 s and 68 °C for 45 s; and 68 °C for 5 min. PCR products were resolved on 3% MetaPhor gel, and fragments (~500-800 bp) were gel excised and purified. Re-PCR was set up with 5 µ M primers that were compatible with the Illumina sequencer and were run at 94 °C for 2 min; six to eight cycles of 94 °C for 20 s, 60 °C for 30 s and 68 °C for 40 s; and 68 °C for 5 min. PCR products were resolved on 3% MetaPhor gels, and fragments (~500-800 bp) were gel excised and purified.
To capture the fraction of 5′ -OH RNA and compare it against that of capped RNAs, total RNA that had been depleted of rRNAs and capped sRNAs was Terminator treated to remove 5′ -P-bearing RNAs, then divided equally into two aliquots. To detect 5′ -OH RNAs, the first aliquot was phosphorylated with T4 PNK in the presence of [γ -32 P]ATP and incubated at 37 °C for 1 h. RNA was phenol/ chloroform (Ambion) extracted and ethanol precipitated. To detect capped RNAs, the second aliquot was first treated with T4 PNK, to phosphorylate any RNAs bearing 5′ -OH, then subjected to Terminator treatment to remove them. RNA was extracted and ethanol precipitated, then treated with tobacco acid pyrophosphatase (TAP, Ambion) at 37 °C for 1 h according to the manufacturer's protocol to remove the 5′ cap, thus leaving a residual 5′ -P. RNA was extracted, ethanol precipitated and treated with CIP at 37 °C for 30 min to remove 5′ -P left by TAP and was then treated with T4 PNK in the presence of [γ - 32 Corresponding author(s): Zissimos Mourelatos
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Replication
Describe whether the experimental findings were reliably reproduced.
There were three biological replicates for Akron5 and 2 biological replicates for Akron3
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization was not relevant; we did not perform experimental manipulations that require randomization
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Randomization was not relevant; we did not perform experimental manipulations that require blinding Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
